ClearNote Health Receives UKCA Mark for Avantect Pancreatic Cancer Test
ClearNote Health has received UKCA marking for its Avantect Pancreatic Cancer Test, enabling commercial availability in the UK.
Read MorePosted by Chris Wolski | Jul 9, 2025 | Pancreatic |
ClearNote Health has received UKCA marking for its Avantect Pancreatic Cancer Test, enabling commercial availability in the UK.
Read MorePosted by Chris Wolski | Jul 7, 2025 | Lab Management |
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
Read MorePosted by Chris Wolski | Jul 1, 2025 | Analytical Software Systems |
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Read MorePosted by Chris Wolski | Jun 30, 2025 | Tissue Processing |
Amsbio has launched Collagenase and Neutral Protease NB enzymes to support high-purity, regulatory-compliant tissue dissociation workflows.
Read MorePosted by Chris Wolski | Jun 23, 2025 | Kidney Disease |
A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.
Read More